LAUPACIS, Andreas. Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 16, n. 2, 2018. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/557. Acesso em: 19 nov. 2024.